Podme logo
HjemOppdagKategorierSøkStudent
Living on Overtime, David C. Fajgenbaum

Living on Overtime, David C. Fajgenbaum

01:10:122019-09-18

Om episode

David Fajgenbaum, a young, promising medical student, could not have imagined he would become a patient in the same hospital he was serving his residency. After being diagnosed with a very rare illness, he came close to death on multiple occasions. In the throes of one encounter, he promised himself that if he survived, he would make a difference in the fight against this disease. Through his research, he found a drug that he believes has helped him into remission. In the wake of his bouts, he has chosen to live his life "on overtime," time that he is extremely lucky to have, gifting him a unique perspective on living we can all learn from. Fajgenbaum is the Co-Founder and Executive Director of the Castleman Disease Collaborative Network and leads the Castleman Research Program at Penn Medicine. He is the author of Chasing My Cure which details his journey of going from a college athlete, living a healthy life to being diagnosed, and the hurdles he had overcome with love, determination and faith. Plug Zone Actively Moving Forward (AMF): https://healgrief.org/ The Castleman Disease Collaborative Network (CDCN): https://cdcn.org/ Book: https://chasingmycure.com/ Twitter: @DavidFajgenbaum Facebook: @davidfajgenbaum, https://www.facebook.com/davidfajgenbaum/ ***VOICEMAILS*** Have a question for Dan? Leave us a voicemail: 646-883-8326 See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

logo

PODME

INFORMASJON

  • Om informasjonskapsler
  • Generelle vilkår
  • Personvernerklæring

LAST NED APPEN

app storegoogle play store

REGION

flag
  • sweden_flag
  • norway_flag
  • finland_flag
redaktorsansvar

Podme arbeider etter Vær Varsom-plakatens regler for god presseskikk. Ansvarlig redaktør og daglig leder er Kristin Ward Heimdal. Redaktør for eksterne innholdssamarbeid er Mathias Thaulow Lisberg.

© Podme AB 2024